Incyte (INCY) Stock Forecast & Price Target

Compare

1,727 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

INCY Analyst Ratings

Moderate Buy

7 Buy

9 Hold

1 Sell

Based on 17 analysts giving stock ratings to

Incyte

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

INCY Stock 12 Month Forecast

Average Price Target

$76.31

▲(7.77%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $76.31 with a high forecast of $107.00 and a low forecast of $52.00. The average price target represents a 7.77% change from the last price of $70.81.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","108":"$108","65.25":"$65.3","79.5":"$79.5","93.75":"$93.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":107,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$107.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76.31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$76.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$52.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,65.25,79.5,93.75,108],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,68.51692307692308,71.72384615384615,74.93076923076923,78.1376923076923,81.34461538461538,84.55153846153846,87.75846153846155,90.96538461538461,94.1723076923077,97.37923076923076,100.58615384615385,103.79307692307692,{"y":107,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,66.15615384615384,67.0023076923077,67.84846153846154,68.69461538461539,69.54076923076923,70.38692307692308,71.23307692307692,72.07923076923078,72.92538461538462,73.77153846153847,74.61769230769231,75.46384615384616,{"y":76.31,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,64.28615384615385,63.262307692307694,62.23846153846154,61.214615384615385,60.190769230769234,59.16692307692308,58.143076923076926,57.11923076923077,56.09538461538462,55.07153846153846,54.04769230769231,53.02384615384615,{"y":52,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":57.79,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.87,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.42,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.66,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.06,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.24,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.16,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.91,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.31,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$107.00

Average Price Target$76.31

Lowest Price Target$52.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$77

Buy

8.74%

Upside

Reiterated

06/12/25

Incyte's strong financial performance and positive earnings call drive the overall score. The stock's high valuation and potential overbought technical indicators are concerns, but strategic initiatives and a robust cash position provide resilience against competitive and operational challenges.

David LebowitzCiti

Citi

$88

Buy

24.28%

Upside

Reiterated

06/26/25

Citi Keeps Their Buy Rating on Incyte (INCY)

Brian AbrahamsRBC Capital

RBC Capital

$67

Hold

-5.38%

Downside

Reiterated

06/26/25

New Incyte CEO fuels M&A speculation, says RBC CapitalNew Incyte CEO fuels M&A speculation, says RBC Capital

Matt PhippsWilliam Blair

William Blair

―

Hold

―

Reiterated

06/26/25

Incyte's Leadership Transition and Pipeline Uncertainty Justify Hold Rating

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

$67.75→$107

Buy

51.11%

Upside

Reiterated

06/23/25

Stifel Nicolaus Sticks to Its Buy Rating for Incyte (INCY)

Andrew BerensLeerink Partners

Leerink Partners

$96

Buy

35.57%

Upside

Reiterated

06/20/25

Monjuvi's Strategic Advantage in Follicular Lymphoma: Analyst Recommends Buy Amid FDA Approval and Projected Revenue Growth

Unknown AnalystEvercore ISI

Not Ranked

Evercore ISI

$73

Hold

3.09%

Upside

Reiterated

06/18/25

Incyte (INCY) Gets a Hold from Evercore ISI

Marc FrahmTD Cowen

TD Cowen

$86

Buy

21.45%

Upside

Reiterated

06/16/25

Incyte (INCY) Receives a Buy from TD Cowen

Jay OlsonOppenheimer

Oppenheimer

$82

Buy

15.80%

Upside

Reiterated

06/16/25

Incyte (INCY) Receives a Buy from Oppenheimer

Kelly ShiJefferies

Jefferies

$76→$82

Buy

15.80%

Upside

Reiterated

06/16/25

Jefferies Remains a Buy on Incyte (INCY)

Tazeen AhmadBank of America Securities

Bank of America Securities

$89

Buy

25.69%

Upside

Reiterated

06/16/25

Promising Phase 1 Results for Incyte's INCA033989 Support Buy Rating Amid Strategic Developments

Derek ArchilaWells Fargo

Wells Fargo

$59

Hold

-16.68%

Downside

Assigned

06/15/25

Incyte's Future Prospects: Balancing Optimism with Caution Amid Pipeline and Patent Challenges

Evan SeigermanBMO Capital

BMO Capital

$52

Sell

-26.56%

Downside

Reiterated

06/15/25

Incyte's Strategic and Financial Challenges Prompt Sell Rating Despite Promising Trial Data

Ashwani VermaUBS

UBS

$61

Hold

-13.85%

Downside

Reiterated

06/11/25

Incyte (INCY) Receives a Hold from UBS

Jessica FyeJ.P. Morgan

J.P. Morgan

$68

Hold

-3.97%

Downside

Reiterated

06/03/25

Incyte (INCY) Gets a Hold from J.P. MorganJPMorgan analyst Jessica Fye reiterated a Neutral rating and $68.00 price target on Incyte (NASDAQ: INCY).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$77

Buy

8.74%

Upside

Reiterated

06/12/25

David LebowitzCiti

Citi

$88

Buy

24.28%

Upside

Reiterated

06/26/25

Citi Keeps Their Buy Rating on Incyte (INCY)

Brian AbrahamsRBC Capital

RBC Capital

$67

Hold

-5.38%

Downside

Reiterated

06/26/25

New Incyte CEO fuels M&A speculation, says RBC CapitalNew Incyte CEO fuels M&A speculation, says RBC Capital

Matt PhippsWilliam Blair

William Blair

―

Hold

―

Reiterated

06/26/25

Incyte's Leadership Transition and Pipeline Uncertainty Justify Hold Rating

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

$67.75→$107

Buy

51.11%

Upside

Reiterated

06/23/25

Stifel Nicolaus Sticks to Its Buy Rating for Incyte (INCY)

Andrew BerensLeerink Partners

Leerink Partners

$96

Buy

35.57%

Upside

Reiterated

06/20/25

Monjuvi's Strategic Advantage in Follicular Lymphoma: Analyst Recommends Buy Amid FDA Approval and Projected Revenue Growth

Unknown AnalystEvercore ISI

Not Ranked

Evercore ISI

$73

Hold

3.09%

Upside

Reiterated

06/18/25

Incyte (INCY) Gets a Hold from Evercore ISI

Marc FrahmTD Cowen

TD Cowen

$86

Buy

21.45%

Upside

Reiterated

06/16/25

Incyte (INCY) Receives a Buy from TD Cowen

Jay OlsonOppenheimer

Oppenheimer

$82

Buy

15.80%

Upside

Reiterated

06/16/25

Incyte (INCY) Receives a Buy from Oppenheimer

Kelly ShiJefferies

Jefferies

$76→$82

Buy

15.80%

Upside

Reiterated

06/16/25

Jefferies Remains a Buy on Incyte (INCY)

Tazeen AhmadBank of America Securities

Bank of America Securities

$89

Buy

25.69%

Upside

Reiterated

06/16/25

Promising Phase 1 Results for Incyte's INCA033989 Support Buy Rating Amid Strategic Developments

Derek ArchilaWells Fargo

Wells Fargo

$59

Hold

-16.68%

Downside

Assigned

06/15/25

Incyte's Future Prospects: Balancing Optimism with Caution Amid Pipeline and Patent Challenges

Evan SeigermanBMO Capital

BMO Capital

$52

Sell

-26.56%

Downside

Reiterated

06/15/25

Incyte's Strategic and Financial Challenges Prompt Sell Rating Despite Promising Trial Data

Ashwani VermaUBS

UBS

$61

Hold

-13.85%

Downside

Reiterated

06/11/25

Incyte (INCY) Receives a Hold from UBS

Jessica FyeJ.P. Morgan

J.P. Morgan

$68

Hold

-3.97%

Downside

Reiterated

06/03/25

Incyte (INCY) Gets a Hold from J.P. MorganJPMorgan analyst Jessica Fye reiterated a Neutral rating and $68.00 price target on Incyte (NASDAQ: INCY).

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Incyte

1 Month

xxx

Success Rate

13/22 ratings generated profit

Average Return

+0.36%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +0.36% per trade.

3 Months

xxx

Success Rate

20/35 ratings generated profit

Average Return

+3.10%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +3.10% per trade.

1 Year

Marc FrahmTD Cowen

Success Rate

27/35 ratings generated profit

Average Return

+10.04%

reiterated a buy rating 12 days ago

Copying Marc Frahm's trades and holding each position for 1 Year would result in 77.14% of your transactions generating a profit, with an average return of +10.04% per trade.

2 Years

xxx

Success Rate

17/22 ratings generated profit

Average Return

+7.16%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 77.27% of your transactions generating a profit, with an average return of +7.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

INCY Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, INCY has received 21 Buy Ratings, 24 Hold Ratings, and 2 Sell Ratings. INCY average Analyst price target in the past 3 months is 76.31.

Each month's total comprises the sum of three months' worth of ratings.

INCY Financial Forecast

INCY Earnings Forecast

Next quarter’s earnings estimate for INCY is $1.40 with a range of $1.06 to $1.78. The previous quarter’s EPS was $1.16. INCY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year INCY has Outperformed its overall industry.

INCY Sales Forecast

Next quarter’s sales forecast for INCY is $1.15B with a range of $1.13B to $1.19B. The previous quarter’s sales results were $1.05B. INCY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year INCY has Outperformed its overall industry.

INCY Stock Forecast FAQ

What is INCY’s average 12-month price target, according to analysts?

Based on analyst ratings, Incyte’s 12-month average price target is 76.31.

What is INCY’s upside potential, based on the analysts’ average price target?

Incyte has 7.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is INCY a Buy, Sell or Hold?

Incyte has a consensus rating of Moderate Buy which is based on 7 buy ratings, 9 hold ratings and 1 sell ratings.

What is Incyte’s price target?

The average price target for Incyte is 76.31. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $107.00 ,the lowest forecast is $52.00. The average price target represents 7.77% Increase from the current price of $70.81.

What do analysts say about Incyte?

Incyte’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of INCY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Incyte (INCY) Stock Forecast & Price Target

INCY Analyst Ratings

INCY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Incyte

INCY Analyst Recommendation Trends

INCY Financial Forecast

INCY Earnings Forecast

INCY Sales Forecast

INCY Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts